Similar articles for PMID: 29179595

Year	Number of Results
1992	1
2003	1
2004	3
2005	1
2006	2
2007	1
2008	2
2009	1
2010	4
2011	3
2012	4
2013	7
2014	12
2015	17
2016	19
2017	24
2018	26
2019	28
2020	22
2021	23
2022	15
2023	8
2024	0

1

Efficacy and safety of aripiprazole lauroxil once-monthly versus aripiprazole once-monthly long-acting injectable formulations in patients with acute symptoms of schizophrenia: an indirect comparison of two double-blind placebo-controlled studies.

Cameron C, Zummo J, Desai D, Drake C, Hutton B, Kotb A, Weiden PJ. Cameron C, et al. Curr Med Res Opin. 2018 Apr;34(4):725-733. doi: 10.1080/03007995.2017.1410471. Epub 2018 Jan 10. Curr Med Res Opin. 2018. PMID: 29179595

2

Aripiprazole Lauroxil Compared with Paliperidone Palmitate in Patients with Schizophrenia: An Indirect Treatment Comparison.

Cameron C, Zummo J, Desai DN, Drake C, Hutton B, Kotb A, Weiden PJ. Cameron C, et al. Value Health. 2017 Jul-Aug;20(7):876-885. doi: 10.1016/j.jval.2017.03.010. Epub 2017 May 9. Value Health. 2017. PMID: 28712616 Free article. Review.

3

A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia.

Meltzer HY, Risinger R, Nasrallah HA, Du Y, Zummo J, Corey L, Bose A, Stankovic S, Silverman BL, Ehrich EW. Meltzer HY, et al. J Clin Psychiatry. 2015 Aug;76(8):1085-90. doi: 10.4088/JCP.14m09741. J Clin Psychiatry. 2015. PMID: 26114240 Free article. Clinical Trial.

4

Aripiprazole long-acting injectable formulations for schizophrenia: aripiprazole monohydrate and aripiprazole lauroxil.

Citrome L. Citrome L. Expert Rev Clin Pharmacol. 2016;9(2):169-86. doi: 10.1586/17512433.2016.1121809. Epub 2015 Dec 19. Expert Rev Clin Pharmacol. 2016. PMID: 26573020 Review.

5

Aripiprazole once-monthly in the acute treatment of schizophrenia: findings from a 12-week, randomized, double-blind, placebo-controlled study.

Kane JM, Peters-Strickland T, Baker RA, Hertel P, Eramo A, Jin N, Perry PP, Gara M, McQuade RD, Carson WH, Sanchez R. Kane JM, et al. J Clin Psychiatry. 2014 Nov;75(11):1254-60. doi: 10.4088/JCP.14m09168. J Clin Psychiatry. 2014. PMID: 25188501 Free article. Clinical Trial.

6

Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison.

Pae CU, Wang SM, Han C, Bahk WM, Lee SJ, Patkar AA, Masand PS, Serretti A, Emsley R. Pae CU, et al. Int Clin Psychopharmacol. 2017 Sep;32(5):235-248. doi: 10.1097/YIC.0000000000000177. Int Clin Psychopharmacol. 2017. PMID: 28430670 Review.

7

Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores.

Ismail Z, Peters-Strickland T, Miguelez M, Baker RA, Hertel P, Eramo A, Jin N, Perry P, Sanchez R, McQuade RD, Kane JM. Ismail Z, et al. J Clin Psychopharmacol. 2017 Jun;37(3):347-350. doi: 10.1097/JCP.0000000000000710. J Clin Psychopharmacol. 2017. PMID: 28383362 Free PMC article. Clinical Trial.

8

Effect of aripiprazole lauroxil in patients with acute schizophrenia as assessed by the Positive and Negative Syndrome Scale-supportive analyses from a Phase 3 study.

Citrome L, Risinger R, Cutler AJ, Du Y, Zummo J, Nasrallah HA, Silverman BL. Citrome L, et al. CNS Spectr. 2018 Aug;23(4):284-290. doi: 10.1017/S1092852917000396. Epub 2017 Jun 19. CNS Spectr. 2018. PMID: 28625204 Clinical Trial.

9

Aripiprazole once-monthly long-acting injectable for the treatment of schizophrenia.

Potkin SG, Preda A. Potkin SG, et al. Expert Opin Pharmacother. 2016;17(3):395-407. doi: 10.1517/14656566.2015.1114100. Expert Opin Pharmacother. 2016. PMID: 26864352 Review.

10

Long-Acting Injectable (LAI) Aripiprazole Formulations in the Treatment of Schizophrenia and Bipolar Disorder: a Systematic Review.

Rapinesi C, Kotzalidis GD, Mazzarini L, Brugnoli R, Ferracuti S, De Filippis S, Cuomo I, Giordano G, Del Casale A, Angeletti G, Sani G, Girardi P. Rapinesi C, et al. Clin Drug Investig. 2019 Aug;39(8):713-735. doi: 10.1007/s40261-019-00801-9. Clin Drug Investig. 2019. PMID: 31152368

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

197 results

Results by year